Cannara Biotech (TSXV:LOVE) Operating Cash Flow per Share : C$0.12 (TTM As of Feb. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Operating Cash Flow per Share?

Cannara Biotech's operating cash flow per share for the three months ended in Feb. 2025 was C$-0.03. Cannara Biotech's operating cash flow per share for the trailing twelve months (TTM) ended in Feb. 2025 was C$0.12.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Cannara Biotech was 18.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Cannara Biotech's Operating Cash Flow per Share or its related term are showing as below:

During the past 7 years, Cannara Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.10% per year. The lowest was -16.70% per year. And the median was 0.20% per year.

TSXV:LOVE's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8.7
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Cannara Biotech Operating Cash Flow per Share Historical Data

The historical data trend for Cannara Biotech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Operating Cash Flow per Share Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.13

-0.03

-0.07

0.07

0.12

Cannara Biotech Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.03	0.05	0.04	0.06	-0.03

Competitive Comparison of Cannara Biotech's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Cannara Biotech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Cannara Biotech's Operating Cash Flow per Share for the fiscal year that ended in Aug. 2024 is calculated as

Operating Cash Flow per Share (A: Aug. 2024 )	=	Cash Flow from Operations (A: Aug. 2024 )	/	Shares Outstanding (Diluted Average) (A: Aug. 2024 )
	=	10.683	/	91.385
	=	0.12

Cannara Biotech's Operating Cash Flow per Share for the quarter that ended in Aug. 2024 is calculated as

Operating Cash Flow per Share (Q: Feb. 2025 )	=	Cash Flow from Operations (Q: Feb. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Feb. 2025 )
	=	-2.55	/	92.254
	=	-0.03

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.12

Cannara Biotech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives

Olymbec Investments Inc.	10% Security Holder
Nicholas Sosiak	Senior Officer
Donald John Olds	Director
Derek Elan Stern	Director
Scott Carroll	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Zohar Krivorot	Director, Senior Officer
Brian Sherman	Senior Officer
Avi Krivorot	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Lennie Ryer	Senior Officer
Jack M. Kay	Director
Donal Carroll	Director or Senior Officer of 10% Security Holder